Researchers at Johns Hopkins University have identified a process in the eye that may explain why biologic drugs for treating ...
A Johns Hopkins study reveals that anti-VEGF treatments for wet AMD may unintentionally elevate ANGPTL4, a protein that ...
Cataracts—a condition that causes clouding of the eye's lens and deteriorating vision—will affect nearly everyone who lives ...
A new study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet age ...
an associate professor of ophthalmology at the Johns Hopkins University School of Medicine, in Baltimore. "What we saw in ...
Current treatments sometimes fail to help people with "wet" age-related macular degeneration -- and researchers now think ...
Study points to approach to improving anti-VEGF therapy for all wet AMD patients, and help subset of patients who lose vision ...
Johns Hopkins Medicine plans to open a new medical ... It will offer primary care and specialties will include cardiology, ophthalmology, gynecology and ear, nose and throat medicine, spokesperson ...